Saturday 17 October 2026
Export ASTH’s income statement to Excel — free account
Astrana Health, Inc.
ASTH Healthcare Medical Care Facilities
Astrana Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 56.4% from fiscal 2024. In the quarter to June 2026, revenue grew 48.5%, EPS grew 110.5%, free cash flow fell 67.7% and total debt rose 126.4%, each against the same quarter a year earlier. Revenue growth for five consecutive years.
36.81
1.22
−3.21%
Follow ASTH
| Mar '17 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | 4 | 6 | 8 | 4 | 5 | 4 | 4 |
P/E ratio |
0.00 | 13.37 | 60.15 | 46.03 | 17.40 | 43.74 | 25.93 | 29.38 | 35.03 | 53.93 |
P/S ratio |
0.00 | 1.59 | 1.26 | 1.14 | 0.97 | 4.16 | 1.11 | 1.30 | 0.74 | 0.38 |
Altman Z-Score |
0.16 | 2.18 | 3.05 | 2.06 | 2.44 | 6.56 | 4.04 | 5.84 | 3.67 | 2.39 |
P/FCF ratio |
6.09 | 12.29 | 26.84 | 50.59 | 14.81 | 63.01 | 21.47 | 45.48 | 33.98 | 11.65 |
Altman Z″-Score (non-manufacturers) |
(9.24) | 1.48 | 3.14 | 2.83 | 3.45 | 4.62 | 4.59 | 5.21 | 3.63 | 2.01 |
P/Operating CF |
10.69 | 39.27 | (102.52) | 178.09 | (256.58) | (264.20) | 14.96 | 93.54 | (137.08) | (421.89) |
Beneish M-Score |
— | — | (0.97) | (2.36) | (2.17) | (2.12) | (2.15) | (2.44) | (1.54) | (2.19) |
P/B ratio |
0.00 | 3.73 | 3.60 | 3.32 | 2.02 | 7.09 | 2.33 | 2.93 | 2.09 | 1.53 |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 50 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 136.95 | 25.79 | 6.41 | 6.78 | 8.37 | 0.00 |
EV/Sales |
0.00 | 1.30 | 1.07 | 1.18 | 0.94 | 4.03 | 1.03 | 1.29 | 0.81 | 0.57 |
EV/EBITDA |
0.00 | 6.03 | 5.01 | 12.44 | 6.46 | 26.71 | 9.63 | 17.29 | 13.83 | 14.24 |
EV/Operating CF |
5.43 | 9.63 | 21.90 | 48.36 | 14.03 | 44.34 | 14.40 | 26.21 | 31.55 | 15.94 |
EV/FCF |
6.00 | 10.03 | 22.96 | 52.35 | 14.38 | 61.02 | 19.98 | 45.05 | 37.29 | 17.48 |
Quick Ratio |
1.01 | 1.27 | 2.30 | 2.81 | 2.80 | 3.33 | 2.76 | 2.03 | 1.68 | 1.35 |
Current Ratio |
1.03 | 1.32 | 2.40 | 3.12 | 2.94 | 3.53 | 2.88 | 2.11 | 1.75 | 1.40 |
Net Debt/EBITDA |
0.37 | (1.99) | (0.85) | 0.42 | (0.20) | (0.87) | (0.72) | (0.16) | 1.23 | 4.75 |
Debt/Assets |
24.52% | 1.25% | 2.64% | 33.22% | 29.53% | 21.29% | 21.25% | 29.94% | 32.08% | 46.82% |
Debt/Equity |
18.72 | 0.04 | 0.07 | 1.26 | 0.73 | 0.41 | 0.38 | 0.45 | 0.61 | 1.31 |
Asset Turnover |
0.31 | 1.39 | 1.04 | 0.90 | 0.89 | 0.92 | 1.25 | 1.46 | 1.78 | 1.78 |
Operating CF/Net income |
0.91 | 2.01 | 2.35 | 0.97 | 1.22 | 1.02 | 1.82 | 1.12 | 1.21 | 5.10 |
Capex/Depreciation |
(0.39) | (0.10) | (0.05) | (0.05) | (0.06) | (1.03) | (1.24) | (1.52) | (0.27) | (0.20) |
Interest Coverage |
(127.10) | 440.98 | 157.63 | 6.85 | 8.47 | 18.20 | 13.16 | 5.25 | 2.70 | 1.57 |
| (23.33%) | 33.62% | 6.27% | 7.55% | 14.41% | 17.56% | 9.05% | 10.46% | 6.47% | 2.98% | |
| (4.84%) | 10.09% | 2.16% | 2.27% | 4.87% | 8.18% | 4.93% | 6.39% | 3.77% | 1.26% | |
ROIC |
0.00% | 42.70% | 63.47% | 9.44% | 16.17% | 17.42% | 14.29% | 8.82% | 6.47% | 3.50% |
Return on Tangible Assets |
(566.17%) | 53.34% | 9.54% | 5.99% | 14.87% | 20.10% | 11.64% | 24.29% | 15.03% | 7.36% |
Average Days of Receivables |
38.06 | 20.61 | 40.34 | 49.50 | 32.20 | 44.95 | 37.20 | 38.89 | 58.27 | 46.19 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
32.36% | 7.37% | 8.34% | 7.40% | 7.15% | 8.02% | 6.79% | 8.12% | 7.57% | 6.83% |
Intangible Assets out of Total Assets |
0.17 | 0.60 | 0.53 | 0.47 | 0.40 | 0.38 | 0.36 | 0.38 | 0.40 | 0.51 |
Share Based Compensation of Revenue |
1.93% | 0.77% | 0.28% | 0.28% | 0.49% | 0.87% | 1.41% | 1.59% | 1.70% | 1.21% |
Graham Net Nets |
(0.02) | (0.30) | (0.24) | (0.32) | (0.22) | 0.00 | 0.00 | 0.08 | 0.00 | (0.46) |
Graham Number |
0.00 | 16.12 | 6.40 | 7.06 | 14.63 | 19.79 | 17.23 | 19.83 | 17.46 | 12.93 |
Earnings Yield |
(19.89%) | 7.48% | 1.66% | 2.17% | 5.75% | 2.29% | 3.86% | 3.40% | 2.85% | 1.85% |
Free Cash Flow Yield |
16.41% | 8.14% | 3.73% | 1.98% | 6.75% | 1.59% | 4.66% | 2.20% | 2.94% | 8.58% |
Revenue per Share |
9.57 | 13.96 | 15.81 | 16.15 | 18.81 | 17.66 | 25.44 | 29.79 | 42.75 | 64.83 |
Operating CF per Share |
(1.36) | 2.03 | 0.78 | 0.39 | 1.26 | 1.60 | 1.83 | 1.47 | 1.10 | 2.34 |
Capex per Share |
(0.05) | (0.08) | (0.04) | (0.03) | (0.03) | (0.44) | (0.51) | (0.61) | (0.17) | (0.21) |
Free Cash Flow per Share |
(1.41) | 1.95 | 0.74 | 0.36 | 1.23 | 1.17 | 1.32 | 0.85 | 0.93 | 2.13 |
Cash per Share |
1.44 | 4.66 | 3.28 | 6.33 | 7.15 | 6.54 | 6.53 | 6.36 | 6.06 | 8.75 |
Shareholders Equity per Share |
0.05 | 6.43 | 5.52 | 5.54 | 9.06 | 10.36 | 12.10 | 13.25 | 15.06 | 16.16 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.05 | 6.43 | 5.52 | 5.54 | 9.06 | 10.36 | 12.10 | 13.25 | 15.06 | 16.16 |
Free Cash Flow |
(8.44) | 49.75 | 24.33 | 12.63 | 45.05 | 51.11 | 59.19 | 39.70 | 44.17 | 104.49 |
Working Capital |
0.38 | 34.56 | 100.84 | 223.64 | 223.59 | 289.74 | 279.52 | 242.83 | 272.89 | 248.04 |
Capital Expenditures |
(0.30) | (2.08) | (1.17) | (1.04) | (1.11) | (19.22) | (22.94) | (28.53) | (8.03) | (10.11) |
Net Current Asset Value |
(5.45) | (182.29) | (158.59) | (207.31) | (148.00) | (8.79) | 6.22 | 144.80 | 0.33 | (562.05) |
EV/EBIT |
0.00 | 8.15 | 6.32 | 20.40 | 8.04 | 31.77 | 11.34 | 21.14 | 18.43 | 23.26 |
Capex to Sales |
0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.02 | 0.02 | 0.02 | 0.00 | 0.00 |
Price to Operating Income |
0.00 | 9.99 | 7.38 | 19.71 | 8.29 | 32.80 | 12.19 | 21.34 | 16.80 | 15.51 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.63 | 1.56 | 1.82 | 1.71 | 0.66 | 0.35 | 0.17 | 2.62 | 2.08 | 0.87 |
Cash ROIC |
(60.27%) | 17.20% | 8.03% | 1.93% | 5.40% | 5.52% | 5.67% | 3.33% | 3.07% | 4.62% |
Accounts Receivable Turnover |
4.06 | 27.30 | 13.40 | 8.40 | 10.06 | 9.93 | 10.80 | 10.49 | 8.61 | 8.75 |
Accounts Payable Turnover |
6.10 | 25.84 | 18.83 | 17.87 | 17.00 | 14.89 | 20.20 | 21.40 | 21.23 | 18.81 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
59.04 | 17.73 | 25.34 | 21.28 | 24.47 | 26.91 | 19.15 | 18.67 | 21.97 | 25.18 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
14.13 | 13.05 | 38.79 | 66.74 | 68.32 | 77.96 | 105.96 | 132.18 | 236.28 | 363.73 |
Average Payables |
7.98 | 10.58 | 19.18 | 26.18 | 31.71 | 40.05 | 46.76 | 54.76 | 83.05 | 151.03 |
Average Assets |
185.32 | 255.64 | 501.82 | 620.86 | 773.10 | 842.42 | 916.79 | 949.79 | 1,144.13 | 1,786.78 |
Average Common Equity |
38.45 | 76.75 | 172.86 | 186.94 | 261.62 | 392.51 | 499.21 | 580.48 | 666.69 | 755.01 |
Columns are period end dates